Gene cluster expression analysis for personalized lung cancer therapy

NewsGuard 100/100 Score

Background and objectives

About 30% of lung cancer patients are accessible to targeted therapy or immunotherapy based on the current criteria. In this study, a novel gene cluster expression analysis was introduced with a goal to potentially expand the treatments to more patients based on the proposed criteria.


Selected gene expression omnibus data sets were downloaded, normalized, and analyzed. A univariate recurrence prediction model was built based on the receiver operating characteristic, for which an optimal cutoff was determined to set abnormality status, called the gene cluster expression index (GCEI). Recurrence and survival risks were calculated and compared between two subgroups indexed by the GCEI. Moreover, a combinatory GCEI was also introduced and its performance was analyzed for combined multiple cluster statuses.


The recurrence risks of the patient subgroups with abnormally expressed clusters with GCEI = 1 were much higher than for the corresponding normal subgroup with GCEI = 0. The higher risks ranged from 120–300% that of the corresponding lower-risk group.


Gene cluster expression index can be used to classify lung cancers with dramatically different recurrence risks and the recurrence risk (percentage) of the patient group with index 1 is typically 20% to 200% higher than the group with index 0. We expect that the higher risk group of index 1 may also be suitable for the corresponding targeted therapy or immunotherapy. Therefore, it may be used to guide targeted therapy or immunotherapy when the conventional companion tests give no recommendation. Nevertheless, this should be validated by clinical trials before it is applied in the clinical practice.

Journal reference:

Rao, A. (2024). Gene Cluster Expression Index and Potential Indications for Targeted Therapy and Immunotherapy for Lung Cancers. Cancer Screening and Prevention/Cancer Screening & Prevention.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
STew: A new method for unveiling the spatial fingerprint of diseases